SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-106538
Filing Date
2019-04-15
Accepted
2019-04-15 16:07:32
Documents
8
Effectiveness Date
2019-04-15

Document Format Files

Seq Description Document Type Size
1 DEFA14A d699078ddefa14a.htm DEFA14A 41883
2 GRAPHIC g699078page003.jpg GRAPHIC 2734
3 GRAPHIC g699078page004a.jpg GRAPHIC 3417
4 GRAPHIC g699078page004b.jpg GRAPHIC 3479
5 GRAPHIC g699078page004c.jpg GRAPHIC 2350
6 GRAPHIC g699078page004d.jpg GRAPHIC 3491
7 GRAPHIC g699078page005.jpg GRAPHIC 2058
8 GRAPHIC g699078page006.jpg GRAPHIC 2051
  Complete submission text file 0001193125-19-106538.txt   70889
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 810930882 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38210 | Film No.: 19748679
SIC: 2836 Biological Products, (No Diagnostic Substances)